White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Neurological Sciences

• Publication date

  2018-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jns.2017.12.018PMID 29406924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interactions of pathological proteins in neurodegenerative diseases

  2017cited by this paper
• Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson’s Disease with Dementia and Dementia with Lewy Bodies

  2016cited by this paper
• Distribution and Load of Amyloid-&bgr; Pathology in Parkinson Disease and Dementia with Lewy Bodies

  2016cited by this paper
• Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales

  2015cited by this paper
• Cognitive assessment tools in Asia: a systematic review

  2015cited by this paper
• Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.

  2015cited by this paper
• Alpha-synuclein and tau: teammates in neurodegeneration?

  2014cited by this paper
• Lewy body disease and dementia with Lewy bodies

  2014cited by this paper
• Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study

  2013cited by this paper
• Functional diversity of protein fibrillar aggregates from physiology to RNA granules to neurodegenerative diseases.

  2013cited by this paper
• Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population

  2012cited by this paper
• White Matter Hyperintensities in Mild Lewy Body Dementia

  2012cited by this paper
• Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

  2012cited by this paper
• Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

  2011cited by this paper
• Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer's Disease

  2011cited by this paper
• Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients With Lewy Body Diseases

  2010cited by this paper
• The clinical use of structural MRI in Alzheimer disease

  2010cited by this paper
• Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body Diseases

  2010cited by this paper
• Understanding White Matter Disease: Imaging-Pathological Correlations in Vascular Cognitive Impairment

  2009cited by this paper
• Cerebral amyloid angiopathy in Lewy body disease

  2008cited by this paper
• Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia

  2008cited by this paper
• Neuropathologic correlates of white matter hyperintensities

  2008cited by this paper
• Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients

  2008cited by this paper
• A Normative Study of the Revised Hasegawa Dementia Scale: Comparison of Demographic Influences between the Revised Hasegawa Dementia Scale and the Mini-Mental Status Examination

  2007cited by this paper
• The enigma of mixed dementia

  2007cited by this paper
• DLB and PDD boundary issues

  2007cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging.

  2006cited by this paper
• Diagnostic Accuracy of Mini-Mental Status Examination and Revised Hasegawa Dementia Scale for Alzheimer’s Disease

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.

  2005cited by this paper
• Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

  2005cited by this paper
• Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

  2003cited by this paper
• Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment

  2002cited by this paper
• beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

  2001cited by this paper
• β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

  2001cited by this paper
• Lewy body variant of Alzheimer's disease: α‐synuclein in dystrophic neurites of Aβ plaques

  2000cited by this paper
• Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques.

  2000cited by this paper
• Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

  2000cited by this paper
• White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging

  1999cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• The Revised Hasegawa's Dementia Scale (HDS-R)-Evaluation of Its Usefulness as a Screening Test for Dementia

  1994cited by this paper
• Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

  1992cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors.

  1988cited by this paper
• MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• This Work Is Licensed under a Creative Commons Attribution 4.0 International License Cortical Tau Load Is Associated with White Matter Hyperintensities

  year unknowncited by this paper

• Compensatory hallucinogenesis across three neuropsychiatric disorders: a Bayesian account

  2026cites this paper
• Testing an inverse link between limbic alpha-synucleinopathy and myelin markers in mice and humans.

  2026cites this paper
• The association between plasma and MRI biomarkers in dementia with lewy bodies

  2025cites this paper
• Neuropsychiatric Symptoms of Alzheimer Disease, Parkinson Disease and Lewy Body Dementia: Genetic, Clinical and Therapeutic Overlaps

  2025cites this paper
• Cerebral small vessel disease in memory center patients with dementia with lewy bodies and Alzheimer’s disease

  2025cites this paper
• Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum

  2025cites this paper
• Comparative analysis of white matter signal alterations in dementia with Lewy bodies and Alzheimer's disease: a systematic review and meta-analysis

  2025cites this paper
• The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms

  2025cites this paper
• White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy.

  2025cites this paper
• Comorbid Pathologies and Their Impact on Dementia with Lewy Bodies—Current View

  2025cites this paper
• Is White Matter Hyperintensity Burden Associated with Cognitive and Motor Impairment in Patients with Parkinson's Disease? A Systematic Review and Meta-Analysis.

  2024cites this paper
• White matter hyperintensities and cholinergic degeneration as Lewy body disease

  2024cites this paper
• Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation

  2024cites this paper
• Dopamine transporter availability based on white matter hyperintensity during early to mid-stage Parkinson’s disease and multiple system atrophy: a case control study

  2024cites this paper
• The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy

  2024cites this paper
• Cerebrovascular and Alzheimer’s disease biomarkers in dementia with Lewy bodies and other dementias

  2024cites this paper
• MRI subtypes in Parkinson’s disease across diverse populations and clustering approaches

  2024cites this paper
• The impact of Bayesian optimization on feature selection

  2024cites this paper
• Effects of white matter hyperintensity on cognitive function in PD patients: a meta-analysis

  2023cites this paper
• White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study

  2023cites this paper
• Temporal Variation in Disease Onset and Clinical Features of Lewy Body Disease in China

  2022cites this paper
• Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study

  2022influential citation
• Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data

  2022cites this paper
• Neuroimaging approaches to cognition in Parkinson's disease.

  2022cites this paper
• Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels

  2022cites this paper
• Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?

  2022cites this paper
• Differential spatial distribution of white matter lesions in Parkinson’s and Alzheimer’s diseases and cognitive sequelae

  2022cites this paper
• White matter hyperintensities in dementia with Lewy bodies are associated with poorer cognitive function and higher dementia stages

  2022cites this paper
• Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design

  2022cites this paper
• Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

  2022cites this paper
• Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies

  2022cites this paper
• Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

  2021cites this paper
• Clinical characteristics of Lewy body dementia in Chinese memory clinics

  2021cites this paper
• Association of Static Posturography With Severity of White Matter Hyperintensities

  2021cites this paper
• Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities

  2021cites this paper
• Prevalence and Associated Factors of Visual Hallucinations in Patients with Vascular Cognitive Impairment

  2021cites this paper
• Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases

  2021cites this paper
• White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis.

  2021cites this paper
• Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies.

  2021cites this paper
• Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum

  2021influential citation
• Translating state-of-the-art brain magnetic resonance imaging (MRI) techniques into clinical practice: multimodal MRI differentiates dementia subtypes in a traditional clinical setting.

  2021cites this paper
• The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease

  2021cites this paper
• The association between white matter hyperintensities, cognition and regional neural activity in healthy subjects

  2021cites this paper
• Implication of Small Vessel Disease MRI Markers in Alzheimer’s Disease and Lewy Body Disease

  2021cites this paper
• A multiparametric MRI study of structural brain damage in dementia with lewy bodies: A comparison with Alzheimer's disease.

  2021cites this paper
• The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson's disease dementia

  2021cites this paper
• [A Parkinson-kórhoz társuló demencia és a Lewy-testes demencia patológiai és klinikai összehasonlítása].

  2020cites this paper
• White matter alterations in Alzheimer’s disease without concomitant pathologies

  2020cites this paper
• Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes

  2020cites this paper
• Prevalence of triple/dual disease (Alzheimer's disease, Lewy body disease, and white matter disease)

  2020cites this paper
• Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.

  2020cites this paper
• A Parkinson-kórhoz társuló demencia és a Lewy-testes demencia patológiai és klinikai összehasonlítása Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies

  2020cites this paper
• A Systematic Review and Implementation of IoT-Based Pervasive Sensor-Enabled Tracking System for Dementia Patients

  2019cites this paper
• Volume of white matter hyperintensities increases with blood pressure in patients with hypertension

  2019cites this paper
• Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders

  2019cites this paper
• Neuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects

  2019cites this paper
• Étude des bases cérébrales de la maladie à corps de Lewy par IRM multimodale

  2019cites this paper
• T1-weighted MRI-driven Brain Age Estimation in Alzheimer’s Disease and Parkinson’s Disease

  2019cites this paper
• [Clinical and neuroimaging heterogeneity of dementia with Lewy bodies].

  2019cites this paper
• Structural and Functional Magnetic Resonance Imaging of Dementia With Lewy Bodies.

  2019cites this paper
• Dementia with Lewy Bodies and Parkinson's Disease-Dementia: Current Perspectives

  2018cites this paper
• Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner.

  2018cites this paper
• Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson’s Disease and Parkinsonism

  2018cites this paper
• Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies

  2018cites this paper